238 related articles for article (PubMed ID: 31680976)
1. Notoginsenoside R1 for Organs Ischemia/Reperfusion Injury: A Preclinical Systematic Review.
Tong Q; Zhu PC; Zhuang Z; Deng LH; Wang ZH; Zeng H; Zheng GQ; Wang Y
Front Pharmacol; 2019; 10():1204. PubMed ID: 31680976
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties and mechanisms of Notoginsenoside R1 in ischemia-reperfusion injury.
Zhu T; Wan Q
Chin J Traumatol; 2023 Jan; 26(1):20-26. PubMed ID: 35922249
[TBL] [Abstract][Full Text] [Related]
3. A Preclinical Systematic Review and Meta-Analysis of Astragaloside IV for Myocardial Ischemia/Reperfusion Injury.
Zheng Q; Zhu JZ; Bao XY; Zhu PC; Tong Q; Huang YY; Zhang QH; Zhang KJ; Zheng GQ; Wang Y
Front Physiol; 2018; 9():795. PubMed ID: 30018562
[TBL] [Abstract][Full Text] [Related]
4. Suppression of NADPH oxidase- and mitochondrion-derived superoxide by Notoginsenoside R1 protects against cerebral ischemia-reperfusion injury through estrogen receptor-dependent activation of Akt/Nrf2 pathways.
Meng X; Wang M; Wang X; Sun G; Ye J; Xu H; Sun X
Free Radic Res; 2014 Jul; 48(7):823-38. PubMed ID: 24720662
[TBL] [Abstract][Full Text] [Related]
5. Ligustrazine Exerts Cardioprotection in Animal Models of Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms.
Zheng Q; Huang YY; Zhu PC; Tong Q; Bao XY; Zhang QH; Zheng GQ; Wang Y
Front Pharmacol; 2018; 9():729. PubMed ID: 30090062
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of notoginsenoside R1 on cerebral ischemia-reperfusion injury in rats.
Zou S; Zhang M; Feng L; Zhou Y; Li L; Ban L
Exp Ther Med; 2017 Dec; 14(6):6012-6016. PubMed ID: 29285151
[TBL] [Abstract][Full Text] [Related]
7. Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction.
Li H; Zhu J; Xu YW; Mou FF; Shan XL; Wang QL; Liu BN; Ning K; Liu JJ; Wang YC; Mi JX; Wei X; Shao SJ; Cui GH; Lu R; Guo HD
Redox Biol; 2022 Aug; 54():102384. PubMed ID: 35777198
[TBL] [Abstract][Full Text] [Related]
8. Danshensu for Myocardial Ischemic Injury: Preclinical Evidence and Novel Methodology of Quality Assessment Tool.
Bao XY; Zheng Q; Tong Q; Zhu PC; Zhuang Z; Zheng GQ; Wang Y
Front Pharmacol; 2018; 9():1445. PubMed ID: 30618743
[No Abstract] [Full Text] [Related]
9. Cardioprotective effects of Notoginsenoside R1 against ischemia/reperfusion injuries by regulating oxidative stress- and endoplasmic reticulum stress- related signaling pathways.
Yu Y; Sun G; Luo Y; Wang M; Chen R; Zhang J; Ai Q; Xing N; Sun X
Sci Rep; 2016 Feb; 6():21730. PubMed ID: 26888485
[TBL] [Abstract][Full Text] [Related]
10. Ginsenoside Rb1 for Myocardial Ischemia/Reperfusion Injury: Preclinical Evidence and Possible Mechanisms.
Zheng Q; Bao XY; Zhu PC; Tong Q; Zheng GQ; Wang Y
Oxid Med Cell Longev; 2017; 2017():6313625. PubMed ID: 29430282
[TBL] [Abstract][Full Text] [Related]
11. Notoginsenoside R1 Regulates Ischemic Myocardial Lipid Metabolism by Activating the AKT/mTOR Signaling Pathway.
Lei W; Yan Y; Ma Y; Jiang M; Zhang B; Zhang H; Li Y
Front Pharmacol; 2022; 13():905092. PubMed ID: 35814216
[TBL] [Abstract][Full Text] [Related]
12. Fasudil, a Rho-Kinase Inhibitor, Exerts Cardioprotective Function in Animal Models of Myocardial Ischemia/Reperfusion Injury: A Meta-Analysis and Review of Preclinical Evidence and Possible Mechanisms.
Huang YY; Wu JM; Su T; Zhang SY; Lin XJ
Front Pharmacol; 2018; 9():1083. PubMed ID: 30327600
[TBL] [Abstract][Full Text] [Related]
13. Effect of tanshinone IIA for myocardial ischemia/reperfusion injury in animal model: preclinical evidence and possible mechanisms.
Zhu PC; Shen J; Qian RY; Xu J; Liu C; Hu WM; Zhang Y; Lv LC
Front Pharmacol; 2023; 14():1165212. PubMed ID: 37261285
[No Abstract] [Full Text] [Related]
14. Ginkgolide B for Myocardial Ischemia/Reperfusion Injury: A Preclinical Systematic Review and Meta-Analysis.
Zhu PC; Tong Q; Zhuang Z; Wang ZH; Deng LH; Zheng GQ; Wang Y
Front Physiol; 2019; 10():1292. PubMed ID: 31681006
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Notoginsenoside R1 via Regulation of the PI3K-Akt-mTOR/JNK Pathway in Neonatal Cerebral Hypoxic-Ischemic Brain Injury.
Tu L; Wang Y; Chen D; Xiang P; Shen J; Li Y; Wang S
Neurochem Res; 2018 Jun; 43(6):1210-1226. PubMed ID: 29696512
[TBL] [Abstract][Full Text] [Related]
16. [Protective effect of notoginsenoside R1 on neuron injury induced by OGD/R through ATF6/Akt signaling pathway].
Hou QL; Wang Y; Li YB; Hu XL; Wang SL
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(6):1167-1174. PubMed ID: 29027434
[TBL] [Abstract][Full Text] [Related]
17. A Preclinical Systematic Review of Curcumin for Protecting the Kidney with Ischemia Reperfusion Injury.
Wang ZH; Deng LH; Chi CW; Wang H; Huang YY; Zheng Q
Oxid Med Cell Longev; 2020; 2020():4546851. PubMed ID: 33274000
[TBL] [Abstract][Full Text] [Related]
18. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
19. Protective effect and possible mechanisms of geniposide for ischemia-reperfusion injury: A systematic review with meta-analysis and network pharmacology of preclinical evidence.
Luo C; Wang L; Wu Y; Liu M; Chen B; Lu Y; Zhang Y; Fu C; Liu X
Heliyon; 2023 Sep; 9(9):e20114. PubMed ID: 37809705
[TBL] [Abstract][Full Text] [Related]
20. Preclinical Evidence of Paeoniflorin Effectiveness for the Management of Cerebral Ischemia/Reperfusion Injury: A Systematic Review and Meta-Analysis.
Wang A; Zhao W; Yan K; Huang P; Zhang H; Ma X
Front Pharmacol; 2022; 13():827770. PubMed ID: 35462929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
